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 Abstract 
 Objective. In hypertensive primary care patients below 65 years of age, (i) to describe the occurrence of undiagnosed 
obstructive sleep apnoea (OSA), and (ii) to identify the determinants of moderate/severe OSA.  Design . Cross-sectional. 
 Setting . Four primary care health centres in Sweden.  Patients. 411 consecutive patients (52% women), mean age 57.9 years 
(SD 5.9 years), with diagnosed and treated hypertension (BP    140/90).  Main outcome measures. Occurrence of OSA 
as measured by the apnoea hypopnoea index (AHI).  Results . Mild (AHI 5 – 14.9/h) and moderate/severe (AHI     15/h) 
OSA were seen among 29% and 30% of the patients, respectively. Comparing those without OSA with those with mild or 
moderate/severe OSA, no differences were found in blood pressure, pharmacological treatment (anti-hypertensive, 
anti-depressive, and hypnotics), sleep, insomnia symptoms, daytime sleepiness, or depressive symptoms. Obesity (BMI 
  30 kg/m2) was seen in 30% and 68% of the patients with mild and moderate/severe OSA, respectively. Male gender, 
BMI     30 kg/m2, snoring, witnessed apnoeas, and sleep duration    8 hours were determinants of obstructive sleep apnoea. 
 Conclusion. Previously undiagnosed OSA is common among patients with hypertension in primary care. Obesity, snoring, 
witnessed apnoeas, long sleep duration, and male gender were the best predictors of OSA, even in the absence of daytime 
sleepiness and depressive symptoms. 
 Key Words:  Depression ,  hypertension ,  obstructive sleep apnoea ,  sleep ,  sleep disordered breathing ,  snoring 
 Background 
 Hypertension (HT) is a common but treatable risk 
factor for cardiovascular disease (CVD) and ischae-
mic heart disease (IHD). The prevalence of HT has 
been estimated to be approximately 30% in the 
United States and 40% in European countries [1]. 
Studies show that obstructive sleep apnoea (OSA) 
occurs in up to one-quarter of men and women in 
the general population [2 – 5] when defi ned as at least 
fi ve respiratory pauses (i.e. apnoeas and hypopnoeas) 
per hour of sleep. It is linked to HT, CVD, IHD, and 
mortality [6,7]. A proposed mechanism is the 
increased cardiovascular stress (i.e. sympathetic acti-
vation) caused by the respiratory disturbance [6]. 
Another link is the shared prevalence of obesity [8]. 
Obesity is signifi cantly less prevalent in Sweden than 
in the United States, where most studies of OSA and 
HT have been conducted. However, recent Swedish 
data indicate an increasing obesity problem [9], which 
might increase the occurrence of OSA. Depression 
and sleep complaints are other prevalent problems 
in primary care. Both are associated with OSA in 
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patients referred to sleep clinics and in the general 
population with poor health perceptions [10]. 
 Two previous Swedish studies [11,12] have inves-
tigated the prevalence of OSA in hypertensive 
patients. Sj ö str ö m et  al. [11] found that 37% of 
middle-aged men had mild OSA and Hedner et  al. 
[12] found a prevalence of 83% having mild OSA in 
patients with both HT and diabetes. However, 
metabolic syndrome is one of the best predictors 
for OSA [13], which might affect the prevalence. 
Furthermore, none of these studies investigated the 
association of OSA with sleep complaints, depres-
sion, and self-rated health, all plausible predictors of 
undiagnosed OSA in a primary care setting. The aim 
of the present study was to (i) describe the occurrence 
of undiagnosed obstructive sleep apnoea (OSA), and 
(ii) identify the determinants of moderate/severe 
OSA in hypertensive primary care patients below 
65 years of age. 
 Material and methods 
 Design and selection criteria 
 A cross-sectional design was used. After ethical 
approval (M29  -  07), all 918 eligible patients 18 – 65 
years of age with diagnosed hypertension (140/90 
mmHg) at four primary care centres in Sweden were 
screened. Exclusion criteria were terminal disease, 
ongoing treatment for OSA, severe psychiatric disease, 
dementia, alcohol/drug abuse, or diffi culties reading 
and understanding the Swedish language. 
 Clinical variables 
 Data regarding weight, height, blood pressure, sub-
jective sleep (i.e. sleep duration, estimated sleep 
need), medication, and comorbidities were collected 
during a clinical examination. Diagnosis of diabetes 
mellitus was based on history, current treatment 
(oral therapy or insulin), or repeated fasting blood 
glucose values    7mmol/l. IHD was defi ned as a his-
tory of angina pectoris and/or myocardial infarction 
and/or coronary angioplasty and/or coronary bypass 
surgery. Respiratory disease was defi ned as a history 
of asthma or chronic obstructive pulmonary disease, 
or on current treatment ( β 2 agonists and/or inhaled 
corticosteroids). 
 Self-rating scales 
 The Berlin Sleep Apnea Questionnaire (BSAQ) (11 
items), focusing on occurrence of OSA symptoms/
characteristics, was used to measure the risk of hav-
ing OSA [14]. The Minimal Insomnia Symptoms 
Scale (three items) was used to measure diffi culties 
initiating sleep, diffi culties maintaining sleep, and 
diffi culties with non-restorative sleep [15]. The patients 
grade their diffi culties on a scale ranging from no 
problems (0), to very great problems (4). The 
Epworth sleepiness scale was used to measure exces-
sive daytime sleepiness (EDS) [16]. The total score 
of the eight items ranged from 0 to 24 points, with 
a cut-off of    10 indicating EDS. The Hospital Anx-
iety and Depression scale (HAD) (14 items) was 
used to measure depressive symptoms [17]. The total 
score of the seven depression items range from 0 to 
21; the higher the score the more depressive symp-
toms. A cut-off of    7 was used to indicate depres-
sive symptoms. The fi rst question concerning current 
health status from the SF-36 was used to measure 
perceived health [18]. The participants ranked their 
health as (1) excellent, (2) very good, (3) good, (4) 
fair, or (5) poor. 
 Recordings of sleep disordered breathing 
 Full-night respiratory recordings with monitoring of 
nasal airfl ow, pulse oximetry, respiratory movements, 
and body position were performed in the patients ’ 
homes using polygraphic equipment [19] (Embletta, 
ResMed AB, Trollh ä ttan, Sweden). Apnoeas and 
hypopnoeas were manually scored. An apnoea was 
scored if the nasal pressure signal amplitude dropped 
   90% for    10 seconds and 90% of the event met 
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amplitude reduction criteria. A hypopnoea was 
scored if the nasal pressure signal amplitude dropped 
   30%, oxygen-saturation dropped    4% for    10 
seconds and 90% of the events met amplitude reduc-
tion criteria. Sleep time was estimated from sleep-log 
and trace patterns. Recordings were scored by the 
second author blinded to the other data. The total 
number of apnoeas and hypopnoeas was divided by 
the estimated sleep time giving the apnoea – hypopnoea 
index (AHI). An oxygen-desaturation index (ODI) 
was calculated in the same manner based on desatura-
tions of    4%. Patients were defi ned as having mild 
OSA or moderate/severe OSA if they had AHI 
5 – 14.9/h or    15/h, respectively. 
 Statistical analysis 
 Categorical data were described with percentages 
and numbers, whereas continuous data were described 
with means and 95% confi dence interval. Normally 
distributed variables were analysed with a  t -test, 
ANOVA, or Pearson correlations. A Mann – Whitney 
test, Kruskal – Wallis test, chi-squared test, or Spear-
man rank correlations were used on non-normally 
distributed or dichotomous variables. To examine 
variables independently associated with AHI   15, 
logistic regression analysis was used. Based on bivariate 
correlations, variables with an association of p    0.20 
with AHI   15 were entered as predictors into a 
multiple logistic regression. The signifi cance level 
was set to p    0.05. All statistical analyses were per-
formed with the PASW statistics 18 (IBM Inc., 
USA). 
 Results 
 Study population 
 Of the 918 patients, 12% (50 men/59 women) were 
excluded and 28% (170 men/159 women) chose not 
to participate. Of the 480 patients who participated 
in the clinical examination, 411 had a respiratory 
recording although 17 were lost due to technical 
problems (Figure 1). Thus, the fi nal study population 
consisted of 394 patients. Population characteristics, 
comorbidities, and medications are given in Table I. 
 Occurrence of OSA 
 It total, 59% of the 394 patients had OSA (AHI   5). 
Mild and moderate/severe OSA occurred among 29% 
and 30% of the patients, respectively. Average ODI 
was four and 16 times as high in the groups with mild 
and moderate/severe OSA (7.9 and 32.0, respectively) 
Step 3: Respiratory recordings during sleep 
Eligible: 411 pts were screened for OSA with a full night polygraphy 
Excluded: 17 pts
Causes for exclusion: recording failures: 10 pts, patients could not accept the equipment: 7 pts 
Final study population: 394 pts 
Step 1: Screening of patients at 4 hypertension clinics 
Eligible: 918 pts 
Excluded: 109 pts 
Causes for exclusion: terminal disease: 8 pts, ongoing treatment for OSA: 17 pts, severe psychiatric disease: 11 
pts, dementia: 8 pts, alcohol/drug abuse: 52 pts, difficulties understanding/reading Swedish: 13 pts 
Did not want to participate: 329 pts 
Step 2: Clinical assessment and self-rating scales 
Eligible: 480 pts were assessed regarding weight, height, and blood pressure. Data regarding medication and 
comorbidities were collected. Self-rating scales for OSA symptoms, sleep, insomnia, daytime sleepiness, 
depressive symptoms, and perceived health were answered. 
Did not want to perform polygraphy: 69 pts 
 Figure 1. Description of design, and number of eligible and excluded patients in the study. 
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 Table I. Characteristics, medication, and comorbidities across the severity groups for obstructive sleep apnoea in hypertensive 
primary care patients below 65 years of age (n    394). 
Characteristics
AHI
    5/h No obstructive sleep 
apnoea n    160, 41%
5 – 14.9/h Mild obstructive 
sleep apnoea n    113, 29%
    15/h Moderate/severe 
Obstructive sleep apnoea 
n    121, 30%
Gender: n (%, CI 95%)
 Men  60 (38, 31 – 46)  57 (50, 40 – 59)  69 (58, 49 – 66)
Age: m [SD] (CI 95%) 57.3 [6.7] (56.3 – 58.4) 57.8 [7.6] (56.4 – 59.1) 58.8 [5.8] (57.4 – 59.5)
Sleep-disordered breathing:
 m [SD] (CI 95%)
 Apnoea – hypopnoea index
 Oxygen desaturation index
 SaO2  – M
 SaO2  – N
 Total desaturations
 Time    90%
 2.1 [1.5] (1.9 – 2.3)
 2.0 [1.5] (1.7 – 2.2)
 94.4 [7.4] (93.2 – 95.6)
 88.7 [7.4] (87.5 – 89.9)
 13.8 [12.2] (11.8 – 15.7)
 0.5 [4.7] (0 – 1.3)
 8.8 [2.7] (8.3 – 9.3)
 7.9 [3.1] (7.3 – 8.5)
 94.0 [3.8] (93.3 – 94.8)
 84.2 [8.6] (82.6 – 85.9)
 52.4 [24.0] (47.9 – 57.0)
 1.4 [4.8] (0.5 – 2.31)
 34.7 [19.1] (31.2 – 38.3)
 32.0 [19.2] (28.5 – 35.5)
 93.1 [1.7] (92.7 – 93.4)
 77.0 [11.5] (74.9 – 79.1)
 195.2 [134.4] (170.6 – 219.8)
 10.6 [13.4] (8.12 – 13.0)
Blood pressure: m [SD] (CI 95%)
 Systolic blood pressure
 Diastolic blood pressure
 138.8 [17.4] (136.0 – 141.5)
 86.4 [9.5] (84.9 – 87.9)
 142.8 [15.8] (139.9 – 145.7)
 87.8 [10.1] (85.9 – 89.7)
 140.6 [18.5] (137.1 – 143.8)
 87.5 [12.0] (85.4 – 89.7)
BMI (kg/m2): m [SD] (CI 95%) 27.0 [4.2] (26.4 – 27.7) 29.1 [4.8] (28.2 – 30.0) 30.8 [5.1] (29.8 – 31.7)
Medication: n (%, CI 95%)
 CA blockers
 Beta-blockers
 ACEI/ARB
 Digoxin
 Diuretics
 Number of hypertensive drugs,
 m [SD] (CI 95%)
 Hypnotics
 Antidepressants
 27 (17, 11 – 23)
 72 (46, 38 – 54)
 90 (57, 50 – 65)
 0
 50 (32, 25 – 39)
 1.5 [0.8] (1.4 – 1.7)
 10 (6, 3 – 10)
 10 (6, 2 – 10)
 23 (20, 13 – 27)
 51 (44, 35 – 53
 68 (59, 50 – 68)
 0
 37 (32, 24 – 41)
 1.5 [0.9] (1.4 – 1.7)
 4 (4, 1 – 7)
 15 (13, 7 – 19)
 30 (25, 16 – 31)
 61 (51, 42 – 60)
 68 (56, 48 – 66)
 1 (0)
 42 (35, 26 – 44)
 1.7 [0.8] (1.5 – 1.8)
 4 (3, 1 – 6)
 13 (11, 5 – 16)
Comorbidities: n (%, CI 95%)
 Diabetes
 Ischaemic heart disease
 Hypercholesterolemia
 Respiratory disease
 TIA/stroke
 20 (22, 8 – 18)
 112 (72, 65 – 79)
 40 (26, 19 – 33)
 10 (6, 3 – 10)
 3 (2, 0 – 3)
 22 (20, 12 – 27)
 82 (72, 64 – 80)
 33 (29, 21 – 38)
 6 (5, 1 – 9)
 2 (2, 0 – 2)
 25 (21, 14 – 29)
 92 (77, 70 – 85)
 41 (35, 27 – 44)
 8 (7, 2 – 11)
 3 (3, 0 – 3)
 Note: The AASM criteria were used when hypertensive primary care patients below 65 years of age were categorized into OSA groups 
based on apnea – hypopnea index    5/h, 5 – 14.9/h, or    15/h. 
 Key: ACEI   angiotensin converting inhibitor; ARB   angiotensin receptor blockers; AHI   apnea – hypopnea index; B-blockers   beta-
blockers; BMI   body mass index; CI 95%    95% confi dence interval; DBP   diastolic blood pressure; HC   hypercholesterolemia, 
IHD   ischaemic heart disease; n   numbers; m   mean; ODI   oxygen desaturation index; RD   respiratory disease; SaO2  – M   mean 
saturation, SaO2  – N   nadir saturation, SBP   systolic blood pressure; TIA/stroke   transient ischaemic attack/stroke. 
compared with those without OSA (2.0) (see Table I). 
Neither systolic or diastolic blood pressure or medica-
tion differed between the two groups of patients with 
OSA, or compared with patients without OSA. BMI 
was signifi cantly associated with AHI. Obesity (BMI 
   30 kg/m2) was seen in 30% and 68% of the patients 
with mild and moderate/severe OSA, respectively. 
 Diabetes was signifi cantly more prevalent among 
patients with at least mild OSA. Neither history of 
IHD nor respiratory disease was associated with 
severity of OSA (see Table I). 
 Differences among OSA groups and determinants 
of OSA 
 No differences were found regarding estimated 
sleep need, sleep suffi ciency index, insomnia, EDS, 
or depressive symptoms with regard to different 
degrees of OSA (Table II). The choice of variables 
included in the regression analysis was based on 
their bivariate relationship to OSA (AHI   15). In 
the fi nal analysis only male gender, BMI   30 kg/m2, 
snoring, reports of witnessed apnoeas, and sleep 
duration   8 hours were signifi cant determinants of 
OSA (AHI   15). Specifi cally, men had 1.7 times 
the odds of having moderate/severe OSA; BMI 
  30 kg/m2 presented 4.0 times the odds; snorers 
had 3.9 times the odds; witnessed apnoeic events 
3.2 times the odds; and sleep duration   8 hours 
had 3.6 times the odds of OSA in this sample 
(Table III). Age, daytime sleepiness, diabetes, 
hypercholesterolemia, perceived health, or depres-
sive symptoms were not signifi cant indicators of 
OSA in this sample. 
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 Table III. Multivariate regression model for apnoea –
 hypopnoea index   15 in hypertensive primary care patients 
below 65 years of age (n    394). 
Variables Odds ratio 95% CI for EXP (B)
Male gender 1.7 1.05 – 2.7
Body mass index     24.9 (ref) (ref)
Body mass index 25 – 29.9 1.6 0.74 – 3.5
Body mass index     30 4.0 1.8 – 9.1
Diabetes 1.08 0.5 – 2.1
Hypercholesterolemia 1.05 0.6 – 1.8
Snoring 3.9 1.3 – 11.6
Witnessed apnoeas 3.2 1.8 – 5.7
Sleep duration    8 hours 3.6 1.03 – 12.8
Perceived health .98 0.7 – 1.3
 Table II. Self-rated sleep, daytime sleepiness, depressive symptoms, and perceived health across the severity groups for 
obstructive sleep apnoea in hypertensive primary care patients below 65 years of age (n    394). 
AHI
Characteristics
    5/h
 No obstructive sleep 
apnoea
 n    160, 41%
5 – 14.9/h
 Mild obstructive sleep 
apnoea
 n    113, 29%
    15/h
 Moderate/severe
 obstructive sleep apnoea
 n    121, 30%
Self-rated sleep: m [SD] (CI 95%)
 Sleep duration, hours
 Estimated sleep need, hours
 Sleep suffi ciency index, %
 6.7 [0.9] (6.5 – 6.8)
 7.6 [0.7] (7.5 – 7.7)
 0.88 [0.1] (0.86 – 0.90)
 6.6 [1.1] (6.4 – 6.8)
 7.8 [0.9] (7.6 – 8.0)
 0.85 [0.1] (0.82 – 0.88)
 7.0 [1.1] (6.8 – 7.2)
 7.9 [1.0] (7.7 – 8.1)
 0.89 [0.1] (0.86 – 0.91)
Self-rated symptoms of obstructive sleep apnoea:
 High risk BSAQ, n (%, CI 95%)
 Snoring, n (%, CI 95%)
 Witnessed apnoeas, n (%, CI 95%)
 92 (60, 52 – 67)
 102 (76, 69 – 83)
 13 (8, 4 – 13)
 95 (84, 77 – 90)
 97 (91, 85 – 96)
 20 (18, 11 – 25)
 108 (91, 86 – 96)
 113 (97, 93 – 99)
 44 (11, 28 – 45)
Insomnia symptoms: n (%, CI 95%)
 Diffi culties initiating sleep
 Diffi culties maintaining sleep
 Diffi culties with non-restorative sleep
 36 (23, 17 – 30)
 73 (47, 39 – 55)
 68 (45, 37 – 53)
 40 (34, 26 – 44)
 68 (60, 52 – 70)
 67 (60, 51 – 69)
 36 (30, 22 – 38)
 58 (48, 40 – 58)
 53 (45, 36 – 53)
Daytime sleepiness:
 Total ESS score, m [SD] (CI 95%)
 ESS    10, n (%, CI 95%))
 7.8 [4.4] (7.1 – 8.6)
 53 (34, 27 – 41)
 7.8 [4.0] (71 – 8.6)
 32 (28, 20 – 36)
 8.3 [4.5] (7.5 – 9.1)
 45 (37, 29 – 46)
Depressive symptoms:
 HAD total score, m [SD] (CI 95%)
 Yes (HAD    7), n (%, CI 95%)
 3.7 [2.5] (3.3 – 4.1)
 19 (13, 7 – 17)
 4.2 [2.5] (3.8 – 4.7)
 21 (19, 12 – 26)
 4.1 [2.6] (3.6 – 4.6)
 21 (18, 11 – 25)
Perceived health: m [SD] (CI 95%) 3.0 [0.8] (2.8 – 3.1) 3.2 [0.9] (3.1 – 3.4) 3.2 [0.9] (3.1 – 3.4)
 Note: The AASM criteria were used when hypertensive primary care patients below 65 years of age were categorized into OSA groups 
based on apnoea – hypopnoea index    5/h, 5 – 14.9/h, or    15/h. 
 Key: AHI   Apnea – hypopnea index; BSAQ   Berlin Sleep Apnea Questionnaire, CI 95%  – 95% confi dence interval; ESS  – Epworth 
sleepiness scale, HAD   Hospital Anxiety and Depression Scale; n   numbers; m  – mean. 
 Discussion 
 The major fi ndings of this study were that more than 
one-half of a cohort of hypertensive primary care 
patients had objective evidence of OSA. But no rela-
tionship between OSA and severity of blood pressure 
elevation, or specifi c comorbid conditions was seen. 
Diabetes, depressive symptoms, insomnia, and EDS 
were common, but not associated with OSA. Male 
gender, BMI   30 kg/m2, snoring, witnessed apnoeas, 
and sleep duration   8 hours were signifi cant correlates 
of OSA. 
 OSA in this sample was more common than that 
found in community-based Scandinavian and Euro-
pean general populations [3 – 5] despite our focus on 
the occurrence of undiagnosed OSA (e.g. patients 
with treated OSA were excluded). This could be 
explained by our selection of hypertensive patients 
[8]. Sj ö str ö m et  al. [11] found in a stratifi ed sample 
of hypertensive men that 37% had AHI   10. In a 
community-based case-control study, Hedner et  al. 
[12] found AHI     10 in 83% of middle-aged patients 
with both HT and diabetes. Comparing our data 
with those from these studies is diffi cult, since they 
used different cut-off scores for AHI and Hedner ’ s 
subjects also had metabolic syndrome, one of the 
best predictors for OSA [13]. 
 Prior studies [20 – 22] have suggested that OSA is 
commonly associated with HT. We found no asso-
ciation between OSA severity and level of blood 
pressure elevation or pharmacological treatment, in 
contrast to previous studies where a dose – response 
relationship was found between night-time blood 
pressure and increasing AHI [23]. This may be due 
to the fact that our patients were already treated for 
HT, mostly successfully. EDS and depressive symp-
toms, commonly assumed as predictors of OSA [13], 
were not associated with OSA although we used 
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validated questionnaires to assess them [16,17]. The 
fact that we did not enrol patients from a sleep clinic 
might explain the lower occurrence of sleeping dif-
fi culties, EDS, and depressive symptoms found com-
pared with other samples [13]. These fi ndings shed 
light on the diffi culties that GPs have in identifying 
patients with OSA in primary care who are in need 
of weight reduction or treatment of OSA [24,25]. 
However, we identifi ed that hypertensive men who 
are obese (i.e. BMI     30 kg/m2), snore, and report 
witnessed apnoeas, as well as long sleep duration (i.e. 
   8 hours) can be suspected to have OSA. Obesity 
is common in sleep clinic patients [8,13], and inten-
sive interventions based on low-calorie diets to reduce 
weight have been shown to decrease AHI [26], but 
long-term results are lacking. Questionnaires, such 
as the BSAQ [14,27], focusing on weight gain/obe-
sity, snoring, witnessed apnoeas, and EDS may, 
together with simple two-channel recording devices 
[28], be suitable in routine screening in primary care 
settings. Importantly, results from the BSAQ and the 
two channel devices are not comparable to validated 
diagnostic tools, such as polygraphy or polysomnog-
raphy, and need to be more thoroughly evaluated 
regarding sensitivity and specifi city. Large, well-
designed studies are therefore needed to explore 
symptom profi les, clinical characteristics, and differ-
ent suitable screening procedures for hypertensive 
patients with undiagnosed OSA of different severity 
levels in primary care settings. Such studies can help 
to identify patients who would benefi t from referral 
to a sleep clinic. 
 We found that desaturations were highly preva-
lent (i.e. mean ODI of 32.0) in those with AHI    
15. Hypoxia is an important contributor to CVD in 
patients with OSA (i.e. by sympathetic activation 
and increased levels of catecholamines, causing 
infl ammation, arterial stiffness, and atherosclerosis) 
[6]. Initiation of continuous positive airway pressure 
(CPAP) can eliminate apnoeas and desaturations, 
and reduce cardiovascular morbidity and mortality 
[29], particularly in patients with severe OSA and 
daytime symptoms. Blood pressure reductions after 
CPAP have been found, especially in sleepy patients 
with frequent desaturations, but also when HT is 
severe, untreated, or refractory [30]. However, the 
effect of CPAP in hypertensive primary care patients 
with OSA, especially those with mild and moderate 
OSA, is unknown. 
 In conclusion, undiagnosed OSA (AHI     15) is 
common in hypertensive primary care patients. Snor-
ing male patients with elevated BMI, long sleep dura-
tion, and witnessed apnoeas should be investigated 
for OSA. Future studies should focus on randomized 
controlled trials evaluating long-term effects of CPAP 
in hypertensive primary care patients with OSA. 
Stratifying men and women with different levels of 
OSA will strengthen the evidence base for treatment. 
Potential confounding factors for CVD, such as obe-
sity, should also be controlled. 
 Limitations of this study include the cross-
sectional design, and the lack of a normotensive con-
trol group matched for age, gender, and BMI, as well 
as the relatively low participation rate. Furthermore, 
no objective data regarding sleep were collected, which 
means that the occurrence of OSA might have been 
even higher since there are diffi culties in estimating 
sleep onset and wake-up time with polygraphy [28]. 
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